Related Experiment Videos

Serum thiocyanate, smoking habits and smoking cessation trial in patients with peripheral atherosclerosis

Insights

Smoking is prevalent in patients with lower limb atherosclerosis. Advising patients to quit smoking yielded disappointing results, with few stopping and some resuming the habit.

Area of Science:

  • Vascular Medicine
  • Cardiovascular Health
  • Smoking Cessation Research

Background:

  • Atherosclerosis in the lower limbs is a significant vascular condition.
  • Smoking is a major risk factor for atherosclerosis and cardiovascular diseases.
  • Understanding smoking habits in this patient group is crucial for intervention.

Purpose of the Study:

  • To investigate smoking habits among patients with lower limb atherosclerosis.
  • To evaluate the effectiveness of advising these patients to quit smoking.

Main Methods:

  • Self-reported cigarette consumption per day.
  • Serum thiocyanate level determination to verify smoking status.
  • Assessment of smoking cessation rates after intervention.

Main Results:

  • High prevalence of smokers and ex-smokers (96% males, 70% females).
  • Smokers underestimated their consumption; serum thiocyanate indicated heavy smoking.
  • Advising cessation was largely ineffective: max 15% quit, some ex-smokers relapsed.

Conclusions:

  • Patients with lower limb atherosclerosis exhibit significant smoking behaviors.
  • Current advice to quit smoking has limited impact on this population.
  • Further research into effective smoking cessation strategies for vascular patients is warranted.

Related Concept Videos